Korean Red Ginseng Extract Increases Apoptosis by Activation of the Noxa Pathway in Colorectal Cancer

Yoon A Jeong1, Bo Ram Kim2, Dae Young Kim1

  • 1Graduate School of Medicine, Korea University College of Medicine, Seoul 02841, Korea.

Nutrients
|September 1, 2019
PubMed
Abstract

Insights

Korean Red Ginseng (KRG) effectively triggers apoptosis and endoplasmic reticulum stress in colorectal cancer (CRC) cells. These findings suggest KRG holds potential as an anticancer drug for CRC patients.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • The anticancer properties of Korean Red Ginseng (KRG) are documented across several cancer types.
  • The specific mechanisms underlying KRG-induced apoptosis in colorectal cancer (CRC) remain largely uncharacterized.

Purpose of the Study:

  • This study aimed to investigate whether KRG can induce apoptosis in colorectal cancer (CRC) cells.
  • To elucidate the molecular pathways involved in KRG's effect on CRC.

Main Methods:

  • Cell viability assays were performed on multiple CRC cell lines.
  • KRG extracts were used at a fixed concentration of 2.5 mg/mL.
  • Apoptosis induction by KRG in CRC cells was confirmed through various experimental assays.

Main Results:

  • KRG treatment led to the activation of Noxa, a key protein in apoptosis.
  • Increased endoplasmic reticulum stress was observed, mediated by reactive oxygen species (ROS) production.
  • KRG demonstrated efficient enhancement of cell death in CRC cells.

Conclusions:

  • The findings indicate that KRG effectively induces apoptosis and endoplasmic reticulum stress in CRC cells.
  • KRG shows promise as a potential therapeutic agent for colorectal cancer.

Related Concept Videos

Generating PDOX Mouse Model of Colorectal Cancer: Studying Progression of Colorectal Cancer in a Murine Model03:19

Generating PDOX Mouse Model of Colorectal Cancer: Studying Progression of Colorectal Cancer in a Murine Model

This video describes the protocol for generating a patient-derived orthotopic xenograft colorectal cancer mouse model to study the progression of colorectal cancer cells in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. This murine model helps in understanding primary tumor growth and metastases...
2.6K
Orthotopic Mouse Model of Colorectal Cancer08:43

Orthotopic Mouse Model of Colorectal Cancer

Two techniques can be used to establish this model: injection of a cancer cell suspension into the cecal wall or transplantation of a piece of subcutaneous tumor onto the cecum. This model is useful for studying the natural progression of colorectal cancer and testing new therapeutic agents against colorectal...
47.1K
Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c07:42

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c

In this protocol, we describe the direct cytoplasmic microinjection of cytochrome c protein into fibroblasts and primary sympathetic neurons. This technique allows for the introduction of cytochrome c protein into the cytoplasm of cells and mimics the release of cytochrome c from mitochondria, which occurs during...
17.8K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Presented here is a protocol to discover the overexpressed driver genes maintaining the established cancer stem-like cells derived from colorectal HT29 cells. RNAseq with available bioinformatics was performed to investigate and screen gene expression networks for elucidating a potential mechanism involved in the survival of targeted tumor...
6.9K
Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer06:49

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

This protocol describes the orthotopic implantation of patient-derived cancer cells in the cecum wall of immunodeficient mice. The model recapitulates advanced colorectal cancer metastatic disease and allows for the evaluation of new therapeutic drugs in a clinically relevant scenario of lung and liver...
2.7K
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Portal vein injection of colorectal cancer (CRC) organoids generates stroma-rich liver metastasis. This mouse model of CRC hepatic metastasis represents a useful tool to study tumor-stroma interactions and develop novel stroma-directed therapeutics such as adeno-associated virus-mediated gene...
7.0K